Increased expression of proinflammatory cytokines and iNOS in the neocortical microvasculature of patients with temporal lobe epilepsy

[1]  A. Vezzani,et al.  Inflammation and reactive oxygen species as disease modifiers in epilepsy , 2020, Neuropharmacology.

[2]  R. Köhling,et al.  Vascular Integrity and Signaling Determining Brain Development, Network Excitability, and Epileptogenesis , 2020, Frontiers in Physiology.

[3]  F. Roche,et al.  Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model , 2020, Brain Research.

[4]  W. Löscher,et al.  Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both? , 2020, International journal of molecular sciences.

[5]  S. Kochen,et al.  Clinical characteristics of psychogenic nonepileptic seizures across the lifespan: An international retrospective study , 2019, Epilepsy & Behavior.

[6]  S. Kochen,et al.  Sex differences in demographic and clinical characteristics of psychogenic nonepileptic seizures: A retrospective multicenter international study , 2019, Epilepsy & Behavior.

[7]  A. Vezzani,et al.  Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy , 2019, Nature Reviews Neurology.

[8]  D. Janigro,et al.  Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy , 2019, Neurobiology of Disease.

[9]  L. Collin,et al.  Intracellular transport and regulation of transcytosis across the blood–brain barrier , 2018, Cellular and Molecular Life Sciences.

[10]  R. Guevara-Guzmán,et al.  Overexpression of inflammatory-related and nitric oxide synthase genes in olfactory bulbs from frontal lobe epilepsy patients , 2018, Epilepsy Research.

[11]  E. Audinat,et al.  Blocking TNFα‐driven astrocyte purinergic signaling restores normal synaptic activity during epileptogenesis , 2018, Glia.

[12]  X. Shao,et al.  Correlation between tumor necrosis factor alpha mRNA and microRNA-155 expression in rat models and patients with temporal lobe epilepsy , 2018, Brain Research.

[13]  A. Vezzani,et al.  Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies , 2018, Epilepsia open.

[14]  C. Riccardi,et al.  Glucocorticoids, Sex Hormones, and Immunity , 2018, Front. Immunol..

[15]  R. Garbelli,et al.  Seizure progression and inflammatory mediators promote pericytosis and pericyte-microglia clustering at the cerebrovasculature , 2018, Neurobiology of Disease.

[16]  E. Aronica,et al.  Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies , 2018, Neuropathology and applied neurobiology.

[17]  S. Orozco-Suárez,et al.  Follow-Up of Peripheral IL-1β and IL-6 and Relation with Apoptotic Death in Drug-Resistant Temporal Lobe Epilepsy Patients Submitted to Surgery , 2018, Behavioral sciences.

[18]  Cheng-xi Wei,et al.  MiR-153 regulates expression of hypoxia-inducible factor-1α in refractory epilepsy , 2018, Oncotarget.

[19]  B. Silva,et al.  Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients , 2017, Journal of Neuroimmunology.

[20]  R. Prayson,et al.  Chronic inflammation in refractory hippocampal sclerosis-related temporal lobe epilepsy. , 2017, Annals of diagnostic pathology.

[21]  K. Elisevich,et al.  Brain region and epilepsy-associated differences in inflammatory mediator levels in medically refractory mesial temporal lobe epilepsy , 2016, Journal of Neuroinflammation.

[22]  H. D. de Vries,et al.  Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition. , 2016, Biochimica et biophysica acta.

[23]  E. Aronica,et al.  Immunity and Inflammation in Epilepsy. , 2016, Cold Spring Harbor perspectives in medicine.

[24]  E. Aronica,et al.  Blood-brain barrier dysfunction, seizures and epilepsy. , 2015, Seminars in cell & developmental biology.

[25]  J. Engel,et al.  Structural and functional correlates of epileptogenesis — Does gender matter? , 2014, Neurobiology of Disease.

[26]  I. Savic.  Sex differences in human epilepsy , 2014, Experimental Neurology.

[27]  Dong Zhou,et al.  Expression of HIF-1α and MDR1/P-glycoprotein in refractory mesial temporal lobe epilepsy patients and pharmacoresistant temporal lobe epilepsy rat model kindled by coriaria lactone , 2014, Neurological Sciences.

[28]  J. Peltola,et al.  Immunological perspectives of temporal lobe seizures , 2013, Journal of Neuroimmunology.

[29]  Nicola Marchi,et al.  Cerebrovascular Remodeling and Epilepsy , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[30]  Alon Friedman,et al.  Overview and introduction: The blood–brain barrier in health and disease , 2012, Epilepsia.

[31]  A. A. Kan,et al.  Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines , 2012, Journal of Neuroinflammation.

[32]  N. Banik,et al.  Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: A review , 2012, Journal of neuroscience research.

[33]  I. Krizbai,et al.  Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages , 2007, Neurochemistry International.

[34]  E. Oby,et al.  The Blood–Brain Barrier and Epilepsy , 2006, Epilepsia.

[35]  R. Simon,et al.  Caspase-3 Cleavage and Nuclear Localization of Caspase-Activated DNase in Human Temporal Lobe Epilepsy , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  A. Pitkänen,et al.  Increased expression of caspase 2 in experimental and human temporal lobe epilepsy , 2007, NeuroMolecular Medicine.